Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
Francesca Bonifazi(University of Bologna), Michele Baccarani(University of Bologna), Giuseppe Saglio(University of Turin), A. Louwagie(Thrombolysis in Myocardial Infarction Study Group), Andreas Hochhaus(Jena University Hospital), Juan Luis Steegmann(Hospital Universitario de La Princesa), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), Antonio De Vivo(Thrombolysis in Myocardial Infarction Study Group), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Giovanni Martinelli(University of Bologna), François Guilhot(Centre Hospitalier Universitaire de Poitiers), Joerg Hasford(Ludwig-Maximilians-Universität München), Elena Trabacchi(Thrombolysis in Myocardial Infarction Study Group), Josef Thaler(Thrombolysis in Myocardial Infarction Study Group), Sue Richards(Oregon Health & Science University), Josy Reiffers(Thrombolysis in Myocardial Infarction Study Group), Enrico Montefusco(Thrombolysis in Myocardial Infarction Study Group), Patricia Shepherd(Thrombolysis in Myocardial Infarction Study Group), Joëlle Guilhot(Inserm), S Tura(University of Bologna), Giuliana Alimena(Thrombolysis in Myocardial Infarction Study Group), François Xavier Mahon(Centre Hospitalier Universitaire de Bordeaux), Gianantonio Rosti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Bengt Simonsson(Uppsala University Hospital), Rüdiger Hehlmann(Heidelberg University)
Cited by 319
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
|Leukemia|2016|849
A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group
|JNCI Journal of the National Cancer Institute|1998|820